27510637

Azziz R

2016

Polycystic ovary syndrome.

27511375

Jahromi MS

2016

Elevated expression of steroidogenesis pathway genes; CYP17, GATA6 and StAR in prenatally androgenized rats.

27511809

Balen AH

2016

The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance.

27511825

Tagliaferri V

2016

The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: an euglycaemic-hyperinsulinaemic clamp study.

27513023

Liu H

2016

Genome-Wide Association Studies for Polycystic Ovary Syndrome.

27513434

Sajjad S

2016

Effects of naloxone and yohimbine in polycystic ovary syndrome: a rabbit model study.

27513883

Cesta CE

2016

Polycystic ovary syndrome and psychiatric disorders: Co-morbidity and heritability in a nationwide Swedish cohort.

27514712

Or?stica L

2016

Altered Steroid Metabolism and Insulin Signaling in PCOS Endometria: Impact in Tissue Function.

27516571

Szyd?o B

2016

Role of omentin and chemerin in metabolic syndrome and tumor diseases.

27516680

Tansaz M

2016

Principles of Nutrition in Patients with Polycystic Ovary Syndrome in Iranian Traditional Medicine and Comparison with Modern Medicine.

27519632

Pretorius E

2017

A new dawn for androgens: Novel lessons from 11-oxygenated C19 steroids.

27525225

Salimi-Asl M

2016

Up-regulation of miR-21 and 146a expression and increased DNA damage frequency in a mouse model of polycystic ovary syndrome (PCOS).

27526420

Mrozi?ska S

2016

There is no difference in the plasma cortisol level between women with body mass index (BMI) greater than or equal 25 kg/m? and polycystic ovary syndrome and the control group without polycystic ovary syndrome and BMI 25 kg/m?.

27526961

Yuan C

2016

Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess: a prospective study.

27529295

Glintborg D

2016

Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.

27529705

Dizon MP

2016

High-value, cost-conscious evaluation for PCOS: which tests should be routinely ordered in acne patients?

27530062

Lizneva D

2016

Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis.

27530294

Nikmard F

2017

Effects of melatonin on oocyte maturation in PCOS mouse model.

27536069

Kia?ka M

2016

Metformin increases pressure pain threshold in lean women with polycystic ovary syndrome.

27541036

Anesetti G

2016

Ovarian follicular dynamics after aromatizable or non aromatizable neonatal androgenization.

27549600

Ingram ER

2016

Utility of antenatal clinical factors for prediction of postpartum outcomes in women with gestational diabetes mellitus (GDM).

27553016

Olguin P

2017

Medical comorbidity of binge eating disorder.

27553217

Huang-TzOu

2016

Metformin improved health-related quality of life in ethnic Chinese women with polycystic ovary syndrome.

27557647

Yu Q

2016

Depression-Like Behavior in a Dehydroepiandrosterone-Induced Mouse Model of Polycystic Ovary Syndrome.

27557677

Dou P

2016

Application of receiver operating characteristic curve in the assessment of the value of body mass index, waist circumference and percentage of body fat in the Diagnosis of Polycystic Ovary Syndrome in childbearing women.

27559705

Rutkowska AZ

2016

Polycystic ovary syndrome and environmental toxins.

27564226

Unfer V

2016

Inositols: from physiology to rational therapy in gynecological clinical practice.

27565256

Walls ML

2016

Structural and morphologic differences in human oocytes after in?vitro maturation compared with standard in?vitro fertilization.

27566840

Dewailly D

2016

Interactions between androgens, FSH, anti-M?llerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary.

27569122

Silva Dantas W

2016

Erratum: GLUT4 translocation is not impaired after acute exercise in skeletal muscle of women with obesity and polycystic ovary syndrome.

27570385

Viswanathan LG

2016

Polycystic ovary syndrome in patients on antiepileptic drugs.

27570464

Gourgari E

2016

Pathophysiology, risk factors, and screening methods for prediabetes in women with polycystic ovary syndrome.

27571186

Dumesic DA

2016

Hyperandrogenism Accompanies Increased Intra-Abdominal Fat Storage in Normal Weight Polycystic Ovary Syndrome Women.

27571188

Abruzzese GA

2017

Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.

27572328

Sarray S

2016

Levels of CD40L and other inflammatory biomarkers in obese and non-obese women with polycystic ovary syndrome.

27575341

Orvieto R

2016

Mono-ovulation in women with polycystic ovary syndrome: the role of step-up, ultra-low-dose gonadotrophin regimen.

27575870

Orio F

2016

Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome.

27577848

Youssef MA

2016

Volume expanders for the prevention of ovarian hyperstimulation syndrome.

27578290

Erkenekli K

2017

Polycystic Ovary Syndrome and Increased Soluble Tumor Necrosis Factor Like Weak Inducer of Apoptosis Levels Are Independent Predictors of Dyslipidemia in Youth.

27579037

Lagan? AS

2016

Metabolism and Ovarian Function in PCOS Women: A Therapeutic Approach with Inositols.

27579518

Behboudi-Gandevani S

2016

Could a body shape index and waist to height ratio predict insulin resistance and metabolic syndrome in polycystic ovary syndrome?

27580534

Beyazit F

2016

Evaluation of Oxidative Stress in Women with Polycystic Ovarian Syndrome as Represented by Serum Ischemia Modified Albumin and Its Correlation with Testosterone and Insulin Resistance.

27580802

Qi X

2016

Neurokinin B Exerts Direct Effects on the Ovary to Stimulate Estradiol Production.

27582109

Sacchi S

2016

Modulation of gonadotrophin induced steroidogenic enzymes in granulosa cells by d-chiroinositol.

27583425

Bucher KG

2016

Alternatives to Metformin for Patients with PCOS.

27590388

Chen CH

2016

Pills-related severe adverse events: A case report in Taiwan.

27593259

Rezaee M

2016

A Review on Glycosylated Hemoglobin in Polycystic Ovary Syndrome.

27593868

Song do K

2016

Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome.

27594563

Mierzwicka A

2016

New peptides players in metabolic disorders.

27595157

Milewska EM

2016

Inositol and human reproduction. From cellular metabolism to clinical use.

27597432

Zhang N

2017

A potential determinant role of adiponectin and receptors for the early embryo development in PCOS patients with obesity hinted by quantitative profiling.

27600201

Huang Y

2016

Letter to the Editor: White Matter Microstructure and Cognitive Function in Young Women With Polycystic Ovary Syndrome by Rees DA, et al.

27601016

Glintborg D

2017

MANAGEMENT OF ENDOCRINE DISEASE: Morbidity in polycystic ovary syndrome.

27603343

Zeng XL

2016

Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome: A meta-analysis.

27603705

Kia?ka M

2016

Pressure pain threshold and Beta-endorphins plasma level are higher in lean polycystic ovary syndrome women.

27609437

Russo V

2016

Polycystic ovary syndrome and arrhythmic risk: the role of comorbidities and the prevalence of interatrial block.

27610099

Lindheim L

2016

The Salivary Microbiome in Polycystic Ovary Syndrome (PCOS) and Its Association with Disease-Related Parameters: A Pilot Study.

27613818

Li T

2017

Role of the PI3K-Akt Signaling Pathway in the Pathogenesis of Polycystic Ovary Syndrome.

27614608

Birch Petersen K

2016

Response to 'Mono-ovulation in women with polycystic ovary syndrome: the role of step-up, ultra-low-dose gonadotrophin regimen'.

27614642

Vahedi M

2016

Metabolic and endocrine effects of bisphenol A exposure in market seller women with polycystic ovary syndrome.

27614897

Chen M

2016

Expression pattern of circadian genes and steroidogenesis-related genes after testosterone stimulation in the human ovary.

27616010

Adamska A

2016

Serum irisin and its regulation by hyperinsulinemia in women with polycystic ovary syndrome.

27617227

Talaat RM

2016

Interleukin 10 (-?1082 G/A) and (-?819 C/T) gene polymorphisms in Egyptian women with polycystic ovary syndrome (PCOS).

27619399

Tan X

2016

Effect of metformin treatment during pregnancy on women with PCOS: a systematic review and meta-analysis.

27619403

Rahmani E

2017

The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome.

27623067

Pierre A

2016

Most Cleaved Anti-M?llerian Hormone Binds Its Receptor in Human Follicular Fluid but Little Is Competent in Serum.

27625565

Tirgar-Tabari S

2016

Hyperprolactinemia and Hirsutism in Patients Without Polycystic Ovary Syndrome.

27627216

Ravindran S

2017

Nephroprotective Effects of Metformin in Diabetic Nephropathy.

27630044

Pfister G

2017

It's not very feminine to have a mustache: Experiences of Danish women with polycystic ovary syndrome.

27634381

Wang Z

2017

Quercetin Decreases Insulin Resistance in a Polycystic Ovary Syndrome Rat Model by Improving Inflammatory Microenvironment.

27634940

Bo?i?-Anti? I

2016

Lipid accumulation product as a marker of cardiometabolic susceptibility in women with different phenotypes of polycystic ovary syndrome.

27635134

Pkhaladze L

2016

Myo-Inositol in the Treatment of Teenagers Affected by PCOS.

27640796

Song S

2016

[Elevated serum levels of betatrophin in patients with polycystic ovary syndrome and the influential factors].

27642107

Tokmak A

2016

Helicobacter pylori infection and polycystic ovary syndrome in adolescent and young adult patients.

27642297

Regidor PA

2016

Myoinositol as a Safe and Alternative Approach in the Treatment of Infertile PCOS Women: A German Observational Study.

27644611

Dashti S

2016

Sexual Dysfunction in Patients with Polycystic Ovary Syndrome in Malaysia.

27648072

Salehpour S

2016

A Potential Therapeutic Role of Myoinositol in the Metabolic and Cardiovascular Profile of PCOS Iranian Women Aged between 30 and 40 Years.

27648099

Shafti V

2016

Comparing Sexual Function and Quality of Life in Polycystic Ovary Syndrome and Healthy Women.

27648989

Velija-Asimi Z

2016

Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome.

27651218

Sathyapalan T

2017

Endocannabinoid receptor blockade increases vascular endothelial growth factor and inflammatory markers in obese women with polycystic ovary syndrome.

27654035

Noroozzadeh M

2017

Sexual function and hormonal profiles in women with and without polycystic ovary syndrome: a population-based study.

27658955

Ou HT

2016

Erratum to: Metformin improved health-related quality of life in ethnic Chinese women with polycystic ovary syndrome.

27662007

Xiang Y

2016

miR-483 is Down-Regulated in Polycystic Ovarian Syndrome and Inhibits KGN Cell Proliferation via Targeting Insulin-Like Growth Factor 1 (IGF1).

27662902

Ubba V

2017

RHOG-DOCK1-RAC1 Signaling Axis Is Perturbed in DHEA-Induced Polycystic Ovary in Rat Model.

27664213

Sundstr?m Poromaa I

2016

Should we individualize lipid profiling in women with polycystic ovary syndrome?

27664216

Bozdag G

2016

The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.

27665725

Matsuzaki T

2017

Kisspeptin mRNA expression is increased in the posterior hypothalamus in the rat model of polycystic ovary syndrome.

27666562

Bjonnes AC

2016

Relationship between polycystic ovary syndrome and ancestry in European Americans.

27667654

Harris HR

2017

Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population-based case-control study.

27668199

Shobeiri F

2016

The association between polycystic ovary syndrome and breast cancer: a meta-analysis.

27677182

Song DK

2016

The Role of Serum MicroRNA-6767-5p as a Biomarker for the Diagnosis of Polycystic Ovary Syndrome.

27678036

Hat?rnaz S

2016

Is elective single-embryo transfer a viable treatment policy in in?vitro maturation cycles?

27679823

Eskandari Z

2016

PCOS women show significantly higher homocysteine level, independent to glucose and E2 level.

27681669

Yong EL

2016

Polycystic Ovarian Syndrome - Issue 30.8.

27683264

Roche J

2016

Apelin (APLN) and Apelin Receptor (APLNR) in Human Ovary: Expression, Signaling, and Regulation of Steroidogenesis in Primary Human Luteinized Granulosa Cells.

27686055

Wang F

2016

Analyses of optimal body mass index for infertile patients with either polycystic or non-polycystic ovary syndrome during assisted reproductive treatment in China.

27688754

Muscogiuri G

2016

Inositols in the Treatment of Insulin-Mediated Diseases.

27688772

Rasekhjahromi A

2016

Herbal Medicines and Ovarian Hyperstimulation Syndrome: A Retrospective Cohort Study.

27690684

Sahin Ersoy G

2017

Novel adipokines WISP1 and betatrophin in PCOS: relationship to AMH levels, atherogenic and metabolic profile.

27692138

Zierau L

2016

Coexistence of asthma and polycystic ovary syndrome: A concise review.